(Press-News.org) Poisons are silent, effective and cheap, making the especially dangerous in Africa where they are used for both pest control and illegal poaching. However, as a new study in Annals of the New York Academy of Sciences reveals, they also kill un-intended wildlife.
Africa has a long history of using poison, both for early tribal warfare and for hunting. Synthetic poisons however were introduced, like so many things, by European colonialists in the 19th century. In southern Africa colonial administrators sanctioned the poisoning of predators and scavengers, a practice which would continue far into the 20th century.
Dr. Darcy Ogada, from The Peregrine Fund, Nairobi, explores the impact of these campaigns and the proliferation of wildlife poisoning in the 1980's and 1990's as the commodification of Africa's natural resources continued to rise. The study reviews legislation across the continent, but finds that legal loopholes and lax enforcement remain barriers to wildlife protection.
After reviewing a breakdown of species whose populations have been ravaged by poisoning, Dr Ogada calls for the establishment of regional pesticide centers across Africa that can identify pesticide hotspots and hold a mandate for chemical testing, education and public engagement.
INFORMATION: END
The power of poison: Study examines pesticide poisoning of Africa's wildlife
2014-03-19
ELSE PRESS RELEASES FROM THIS DATE:
Youth, wealth and education found to be risk factors for violent radicalization
2014-03-19
New research from Queen Mary University of London has found youth, wealth, and being in full-time education to be risk factors associated with violent radicalisation. Contrary to popular views – religious practice, health and social inequalities, discrimination, and political engagement showed no links.
The pioneering research assessed population prevalence of sympathies for terrorist acts – a key marker of vulnerability to violent radicalisation – and their relationship with commonly assumed causes of radicalisation. The community study surveyed over 600 men and women ...
Fast synthesis could boost drug development
2014-03-19
CAMBRIDGE, MA -- Small protein fragments, also called peptides, are promising as drugs because they can be designed for very specific functions inside living cells. Insulin and the HIV drug Fuzeon are some of the earliest successful examples, and peptide drugs are expected to become a $25 billion market by 2018.
However, a major bottleneck has prevented peptide drugs from reaching their full potential: Manufacturing the peptides takes several weeks, making it difficult to obtain large quantities, and to rapidly test their effectiveness.
That bottleneck may soon disappear: ...
Humans drive evolution of conch size
2014-03-19
The first humans to pluck a Caribbean fighting conch from the shallow lagoons of Panama's Bocas del Toro were in for a good meal. Smithsonian scientists found that 7,000 years ago, this common marine shellfish contained 66 percent more meat than its descendants do today. Because of persistent harvesting of the largest conchs, it became advantageous for the animal to mature at a smaller size, resulting in evolutionary change.
Human-driven evolution of wild animals, sometimes referred to as "unnatural selection," has only previously been documented under scenarios of high-intensity ...
Statins slow the progression of advanced multiple sclerosis in clinical trial
2014-03-19
Statins may provide doctors with an unlikely new weapon with which to slow the progression of multiple sclerosis (MS).
No treatments can currently abate the advanced stage of the disease, known as secondary progressive MS, which gradually causes patients to become more disabled.
In a two-year clinical trial involving 140 patients with secondary progressive MS, the drug simvastatin slowed brain shrinkage, which is thought to contribute to patients' impairments. Supporting this finding, patients on simvastatin achieved better scores on movement tests and questionnaires ...
Fried foods may interact with genes to influence body weight, say experts
2014-03-19
The results show that eating fried food more than four times a week had twice as big an effect on body mass index (BMI) for those with the highest genetic risk scores compared with lower scores. In other words, genetic makeup can inflate the effects of bad diet, says an accompanying editorial.
It is well known that both fried food consumption and genetic variants are associated with adiposity (fatness). However, the interaction between these two risk factors in relation to BMI and obesity has not been examined.
So a team of US researchers, led by Lu Qi, Assistant Professor ...
NHS sight tests lead to waste
2014-03-19
Michael Clarke, Consultant Ophthalmologist at Newcastle Eye Centre, says that apart from trauma and orthopaedics, ophthalmology receives more NHS outpatient referrals than any other speciality.
He says that opticians are constrained by legislation to refer patients to a medical practitioner if abnormalities are found at an NHS sight test. However, the testing done at NHS sight tests has become more complex and many patients are now referred with clinically insignificant abnormalities, leading to wastage of appointments in Hospital Eye Services.
So called 'Eye Health ...
Risk of obesity from regular consumption of fried foods may depend on genetic makeup
2014-03-19
Boston, MA —People with a genetic predisposition to obesity are at a higher risk of obesity and related chronic diseases from eating fried foods than those with a lower genetic risk, according to a new study from researchers from Harvard School of Public Health, Brigham and Women's Hospital, and Harvard Medical School. It is the first study to show that the adverse effects of fried foods may vary depending on the genetic makeup of the individual.
"Our study shows that a higher genetic risk of obesity may amplify the adverse effects of fried food consumption on body weight, ...
The Lancet: Statin may slow untreatable, progressive stage of multiple sclerosis
2014-03-19
Results of a phase 2 study published in The Lancet suggest that simvastatin, a cheap cholesterol lowering drug, might be a potential treatment option for the secondary progressive, or chronic, stage of multiple sclerosis (MS), which is currently untreatable.
Findings from the MS-STAT trial showed that a high, daily dose of simvastatin was safe, well tolerated, and slowed brain atrophy (shrinkage) by 43% over two years compared with placebo. Longitudinal studies suggest that atrophy progression is linked with disability.
In its early stages, MS is characterised by intermittent ...
Tamiflu® reduces risk of death by 25 percent in adults hospitalised with H1N1 pandemic influenza
2014-03-19
Adults hospitalised with H1N1 influenza during the 2009-2010 pandemic were 25% less likely to die from the disease if they were given antiviral drugs called neuraminidase inhibitors (NAIs) such as Tamiflu®, according to a large meta-analysis involving more than 29 000 patients from 38 countries, published in The Lancet Respiratory Medicine journal. The findings also indicate that treatment within 2 days of flu symptoms developing halved the risk of death compared with later treatment or no treatment.
"Many governments have stockpiles of Tamiflu that are close to expiry. ...
Increased adiposity and reduced physical activity in children: Cause or effect?
2014-03-18
Increased adiposity is likely to cause reduced physical activity in children, according to research published in this week's PLOS Medicine. The results of the study, conducted by Rebecca Richmond and colleagues from the MRC Integrative Epidemiology Unit at the University of Bristol, UK, suggest that promoting weight loss in overweight and obese children might also increase childhood activity levels.
Previous studies have shown an association between low physical activity and higher body mass index (BMI) in children but were not able to determine whether childhood adiposity ...